Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
作者信息
Hubers Scott A, Brown Nancy J
机构信息
From Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
出版信息
Circulation. 2016 Jul 19;134(3):e11-2. doi: 10.1161/CIRCULATIONAHA.116.023311.
Abstract
摘要
相似文献
1
Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".休伯斯和布朗对关于《联合血管紧张素受体拮抗与中性肽链内切酶抑制》一文的信件的回应。
Circulation. 2016 Jul 19;134(3):e11-2. doi: 10.1161/CIRCULATIONAHA.116.023311.
2
Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
Circulation. 2016 Jul 19;134(3):e9-e10. doi: 10.1161/CIRCULATIONAHA.116.023086.
3
Heart failure: another new PARADIGM in treatment for heart failure?心力衰竭：心力衰竭治疗的另一种新范式？
Nat Rev Cardiol. 2015 Jan;12(1):4. doi: 10.1038/nrcardio.2014.195. Epub 2014 Dec 2.
4
Angiotensin receptor neprilysin inhibitors in older patients with heart failure.血管紧张素受体脑啡肽酶抑制剂用于老年心力衰竭患者
BMJ Evid Based Med. 2019 Feb;24(1):5-7. doi: 10.1136/bmjebm-2018-110949. Epub 2018 Jul 10.
5
Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?血管紧张素受体-中性肽链内切酶抑制在射血分数降低的心力衰竭中的应用：适用于所有人的范例？
JACC Heart Fail. 2016 Oct;4(10):823-825. doi: 10.1016/j.jchf.2016.07.013. Epub 2016 Sep 7.
6
Angiotensin receptor-neprilysin inhibitors in heart failure: a shifting paradigm.
Evid Based Med. 2015 Apr;20(2):61. doi: 10.1136/ebmed-2014-110112. Epub 2015 Feb 6.
7
Neprilysin inhibition for heart failure.用于心力衰竭的中性肽链内切酶抑制作用
N Engl J Med. 2014 Dec 11;371(24):2336-7. doi: 10.1056/NEJMc1412654.
8
Neprilysin inhibition for heart failure.用于心力衰竭的中性肽链内切酶抑制作用
N Engl J Med. 2014 Dec 11;371(24):2335. doi: 10.1056/NEJMc1412654.
9
Neprilysin inhibition for heart failure.
N Engl J Med. 2014 Dec 11;371(24):2335-6. doi: 10.1056/NEJMc1412654.
10
Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?联合抑制中性肽链内切酶和肾素-血管紧张素系统治疗心力衰竭：竭肾之力救心？
Eur J Heart Fail. 2015 May;17(5):468-71. doi: 10.1002/ejhf.267.
引用本文的文献
1
Breaking barriers: Neprilysin inhibition in chronic cardiorenal syndrome.突破障碍：慢性心肾综合征中的中性内肽酶抑制作用
World J Cardiol. 2025 Jul 26;17(7):107539. doi: 10.4330/wjc.v17.i7.107539.
本文引用的文献
1
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.血管紧张素受体拮抗剂与中性内肽酶抑制剂联合使用
Circulation. 2016 Mar 15;133(11):1115-24. doi: 10.1161/CIRCULATIONAHA.115.018622.
2
The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects.LCZ696（沙库巴曲/缬沙坦）对健康受试者脑脊液中β淀粉样蛋白浓度的影响。
Br J Clin Pharmacol. 2016 May;81(5):878-90. doi: 10.1111/bcp.12861. Epub 2016 Mar 8.
Zotero 插件